This document discusses a case of esophageal cancer in a 65-year-old male who presented with dysphagia, weight loss, and chest pain. Examination found weight loss and endoscopy revealed an ulcerated mass in the mid-esophagus. The document provides information on the anatomy and types of esophageal cancers. It discusses risk factors, symptoms, investigations including endoscopy, biopsy and imaging. Staging, treatment options including surgery, chemotherapy and radiation are outlined. Prognosis is generally poor but research on neoadjuvant immunotherapy and chemotherapy is showing promise in improving outcomes.
The stomach J-shaped. It has two surfaces (the anterior & posterior), two curvatures (the greater & lesser), two orifices (the cardia & pylorus). It has fundus, body and pyloric antrum.
Blood supply
The left gastric artery
Right gastric artery
Right gastro-epiploic artery
Left gastro-epiploic artery
Short gastric arteries
Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years.
It could be:
malignant or benign
primary or secondary
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The stomach J-shaped. It has two surfaces (the anterior & posterior), two curvatures (the greater & lesser), two orifices (the cardia & pylorus). It has fundus, body and pyloric antrum.
Blood supply
The left gastric artery
Right gastric artery
Right gastro-epiploic artery
Left gastro-epiploic artery
Short gastric arteries
Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years.
It could be:
malignant or benign
primary or secondary
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
4. Case Presentation
A 65yr old male presented in OPD with chief
complains of progressive dysphagia, weight loss and
occasional chest pain.
Patient is a known case of GERD since 2 years,
along with a 40-pack year smoking hx and heavy
alcohol consumption. He is a retired construction
worker, exposed to carcinogens, and has a
sedentary/unhealthy lifestyle.
On examination, patient is pale appearing and has
lost over 10kgs over the last few months.
Upper GI endoscopy reveals a circumferential
ulcerated mass in mid-esophagus & CT scan reveals
esophageal wall thickening
9. Esophageal Carcinomas
It is the 6th most common cancer in the world
Mostly presents in mid to late adulthood
Has a poor prognosis, only 5-10% of those diagnosed will survive beyond
5 years
13. ENDOSCOPY – 1st line
BIOPSY – for histology & cytology is crucial for accurate diagnosis
BARIUM SWALLOW
CT/MRI
BRONCHOSCOPY
LAPROSCOPY
ENDOSCOPIC US and/or PET SCAN
Investigations
14. • Esophageal CA is almost always diagnosed by endoscopic biopsy
• Endoscopy should be performed in every patient with dysphagia, even if the
barium study is suggestive of a motility disorder
• Contrast-enhanced CT scan of the chest and abdomen, and PET scan should be
done to assess for distant metastasis
• If there is no evidence of distant metastatic disease, endoscopic US should be
performed to assess T-stage and regional lymph nodes involvement
17. NICE Guidelines for oesophagogastric
cancer - NG83
• Offer PET-CT for esophageal and gastro-esophageal junctional tumors that are suitable for radical
treatment
• Do not use endoscopic ultrasound only to distinguish between T2 and T3 tumors
• Only offer endoscopic ultrasound when it will help guide ongoing management
• Only consider staging laparoscopy when it will help guide ongoing management
• Offer HER2 testing in metastatic esophagogastric adenocarcinoma
• Offer endoscopic resection for staging in people with suspected stage 1 esophageal
adenocarcinoma
18. TNM Staging
Tis High grade dysplasia
T1 Tumor invading lamina propria or submucosa
T2 Tumor invading muscularis propria
T3 Tumor invading beyond muscularis propria
T4 Tumor invading adjacent structures
Tx Primary tumor cannot be assessed
N0 No regional lymph node metastases
N1 Regional lymph node metastases
Nx Lymph nodes cannot be assessed
M0 No distant metastases
M1(a) Celiac node involved (distal tumors)
Supraclavicular node involved (proximal tumors)
M1(b) Celiac or supraclavicular node involved if not remote from tumor site (i.e. not 1a)
All distant metastases
Mx Distant metastases cannot be assessed.
27. • Fan et al., conducted a meta-analysis of 27 phase-II/III clinical trials, incorporating a total of 815 patients, with
resectable stage I-IV esophageal CA.
• The main objective of this meta-analysis was to systematically assess and provide the most updated and
comprehensive evidence regarding the safety & efficacy of neoadjuvant immunotherapy combined with
chemotherapy, in patients with resectable esophageal CA.
• The primary outcomes were the pathological complete response (pCR) rate and the major pathological response
(MPR) rate. Secondary outcomes were treatment-related severe adverse events.
• pCR: 31.4% (95% CI: 27.6-35.3) & MPR: 48.9% (95% CI: 42.0-55.9).
• Severe adverse events: 26.9% (95% CI: 16.7-38.3)
• The study demonstrated promising clinical & safety outcomes with neoadjuvant therapy combined with chemo in
patients with resectable esophageal CA. Supports the prospective wide application of this treatment option.
29. Types of gastro oesophageal junction
cancer
• Type 1
Type 1 GOJ cancer spreads down into the gastro oesophageal junction from above. So, the cancer cells are in the lower
part of the oesophagus and the gastro oesophageal junction. The cancer’s centre is between 1 and 5 cm above the
junction.
• Type 2
Type 2 GOJ cancers develop at the actual gastro oesophageal junction. The cancer's centre is between 1 cm above and 2
cm below the junction.
• Type 3
Type 3 GOJ cancer spreads up into the gastro oesophageal junction from below. So there are cancer cells in the top of the
stomach and the gastro oesophageal junction. The cancer’s centre is between 2 and 5 cm below the junction.
32. Risk Factors
There are different risks factors for each type of GOJ cancer.
• Type 1
Type 1 GOJ cancers are similar to oesophageal cancers. Barrett's oesophagus increases your risk of type 1 GOJ cancer. This is a condition
where the cells lining your oesophagus have become abnormal. This can happen due to long term acid indigestion (acid reflux).
• Type 2
We don't have such a good understanding of what causes type 2 cancers. Type 2 characteristics are somewhere between stomach and
oesophageal cancer cells.
• Type 3
Type 3 GOJ cancers are similar to stomach cancers. They are linked to infection with Helicobacter pylori (H.pylori). H. pylori is a bacteria
that lives in the mucous of the lining of the stomach.
37. Endoscopic picture
A view through the
endoscope (Fig A) shows an
ulcerated mass in the distal
esophagus at the
gastroesophageal (GE)
junction, which appears
malignant.
It is arising from abnormal,
pink mucosa (Barrett’s
mucosa)
38. Radiographic imaging
Fig A: Radiographs from a double-contrast upper
gastrointestinal series show an eccentric filling defect
in the anterolateral portion of the distal esophagus
Fig B: There is irregularity of the distal esophageal
wall, a finding consistent with severe erosive changes,
probably from reflux.
Fig C: Axial CT of the upper abdomen (without the
administration of intravenous contrast material shows
thickening of the right anterolateral wall of the distal
esophagus (arrow), corresponding in location to the
mass seen on the upper gastrointestinal study.
Fig D: There is an enlarged (1.0 cm)
lymph node in the gastrohepatic ligament
39. Fig: Adenocarcinoma at the
gastroesophageal junction with
central depression shown by
asterisk.